Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Sleep Disorders, Circadian Rhythm 1Sleep Deprivation 1REM Sleep Behavior Disorder 1Psychological Well-Being 1Pain 1Idiopathic Hypersomnia 1Depression 1Combat Disorders 1Chronobiology Disorders 1Cancer Pain 1Anxiety Disorders 1Alzheimer Disease 1

Interventions

pembrolizumab 301Paclitaxel 206Carboplatin 199Gemcitabine 173Cisplatin 138Docetaxel 137Cyclophosphamide 135Nivolumab 129Bevacizumab 118Injections 111fludarabine 95atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 70Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Propofol × Clear all
NCT06644573 2025-05-28

PSHW

PROSOMNIA Sleep Health & Wellness

Phase 1 Not yet recruiting
100 enrolled

Cancer Pain, Psychological Well-Being, Alzheimer Disease, Anxiety Disorders, Combat Disorders, Depression, Sleep Initiation and Maintenance Disorders, Pain, Sleep Deprivation, Stress Disorders, Post-Traumatic, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, REM Sleep Behavior Disorder, Chronobiology Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡